Clinical trials
Phase 1/2 Neuroblastoma trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 2 |
| Novartis Pharmaceuticals | 2 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Eli Lilly and Company | 1 |
| Genzyme, a Sanofi Company | 1 |
| Merck Sharp & Dohme LLC | 1 |
| St. Anna Kinderkrebsforschung | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroblastoma | 10 |
| Sarcoma, Ewing | 5 |
| Glioma | 4 |
| Medulloblastoma | 4 |
| Rhabdomyosarcoma | 4 |
| Brain Neoplasms | 3 |
| Neoplasms | 3 |
| Recurrence | 3 |
| Ependymoma | 2 |
| Melanoma | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.